420 with CNW — Mississippi Governor Signs Medical Cannabis Bill into Law

Last week, Mississippi became the 37th U.S. state to legalize the use of medical marijuana. Gov. Tate Reeves signed the bill into law stating that it would provide medical marijuana to individuals who “could do significantly better” with prescribed doses. According to the National Conference of State Legislatures (“NCSL”), the state joins 36 states and territories including Puerto Rico, the District of Columbia, the Virgin Islands and Guam, where the use of medical marijuana is legal.

The Republican governor mentioned through a statement that a recreational program would not only lead to an increase in users but also reduce performance and bring about societal ills.

This new legislation will see patients diagnosed with AIDS, cancer, autism, Parkinson’s disease, Crohn’s disease and more become eligible to buy medical marijuana with a card. The card will be obtained from the state’s Department of Health after an in-person examination from a qualified health-care worker.

The law will allow patients to receive at most six units per week and 24 units in 30 days. The law describes one unit as either 100mg of THC in an infused product, 3.5g of medical cannabis or 1g of medical cannabis concentrate. Employers, landlords and schools cannot discriminate against card holders under the law. Moreover, it restricts dispensaries from being situated within 1,000 feet of any churches, schools or child-care facilities without a waiver.

The law specifies that plants must be cultivated indoors under restrictive conditions. Taxes have been set on cannabis production and sales while also denying the state the ability to provide any incentive for economic development to cannabis businesses. The legislation will allow counties and cities to opt out in allowing any facilities from growing or selling medical marijuana.

An earlier drafted bill had set the purchase limit to 28 grams each month. However, it was struck down in November 2020 by Mississippi’s Supreme Court. Reeves has described the legislation as being imperfect. However, he sees that its restrictiveness will reduce the number of marijuana blunts in the streets by “hundreds of millions.”

One of the groups that pushed for marijuana’s legalization is the Mississippi Medical Marijuana Association. The association’s executive director, Ken Newburger, said that the laws would improve the quality of life of individuals who would gain the benefits of medical cannabis.

The bill has been tracked down by NORML, which has said that it was long overdue. Jax James, the organization’s state policies manager, says that the law had received overwhelming support from voters over the years. He says that for the last 14 months the people’s wish has been denied.

The signing of this bill into law is likely to trigger a flurry of new economic activity, including the attraction of new and existing marijuana companies such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) that are working to meet the growing needs of patients in Mississippi.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — New VA Website Seeks to Normalize Conversations Around Marijuana Research

A new website is being launched by the U.S. Department of Veteran Affairs (“VA”) with the aim of normalizing conversations around cannabis research. The department’s Portland Branch is partnering with Oregon Health & Science University (“OHSU”) to support healthcare service providers with the latest research on marijuana.

Many VA doctors are reluctant to talk to their patients about the use of cannabis for treatment because of the drug’s federal prohibition: federal law allows VA doctors to talk to their patients about cannabis, but they are not allowed to offer any recommendations. Together with the university’s Center for Evidence-based Policy, the Portland branch launched the Systematically Testing the Evidence on Marijuana (“STEM”) initiative last month. The STEM website would address doctors’ concerns by familiarizing them with marijuana’s health effects.

OHSU professor Devan Kansagara said the reason why providers cannot make recommendations about treatment is because of a lack of evidence of the health effects as well as a lack of understanding of the terminology and functional issues of cannabis. Through a press release, the professor who is also a staff physician, said that the site would make it normal for providers to discuss cannabis with their patients the same way they talk about alcohol use.

The site will contain published information around cannabis studies, including those whose research is currently ongoing; the site will also provide additional resources for the health practitioners. These resources include “living reviews” when cannabis is used for chronic pain, PTSD and interventions for cannabis use disorder as well as information on clinical trials, policies and specific related news. The website has already featured one study that indicates the effectiveness of cannabis compounds in preventing COVID-19 infections.

The content on the STEM website targets health-care workers and does not take any stance on the integration of cannabis into treatment. In its future developments, the website looks to include content tailored to patients as well.

The Department of Veteran Affairs has had a long history of resisting legislation from Congress that seeks to promote marijuana research for veterans. Department officials argue that some of the proposals are redundant and prescriptive. However, this might change through proposals that call for modest reforms.

A VA researcher recognized in December that marijuana helps people who suffer from PTSD experience lesser symptoms and a quicker recovery. In September, another official said that the agency was monitoring research on the benefits of psychedelics for military veterans suffering from PTSD.

VA Secretary Denis McDonogh talked of an internal policy during a Q&A session on Veterans Day. He made the revelations after hearing stories from veterans who had found relief in the treatment. The secretary has said that he is in discussions on the matter with the Department of Justice as well as the White House.

The fact that agencies such as the Department of Veterans Affairs are beginning to warm up to the therapeutic potential of cannabis bodes well for the future of sector players such as American Cannabis Partners because federal prohibition may end much sooner than previously thought.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – VPR Brands LP (VPRB) Unveils New Dissim Sport and Dissim Slim Lighters to ‘Best Focus Group’ for Pre-Launch Reaction

VPR Brands (OTC: VPRB) recently debuted its new Dissim Sport and Dissim Slim Line Lighters at the 2022 TPE Tobacco Plus Expo, held in Las Vegas from Jan. 26-28, 2022, and the Champs Trade Show on Feb. 2-5, 2022, at the Las Vegas Convention Center. According to the update, the Slim and Sport line within the Dissim family of lighters will launch with an opening price point between $8-$28 MSRP respectively and are expected to bring a new audience and open new distribution channels. “I personally attended TPE this year so I could interact with the distributors firsthand and gauge their reaction by actually letting these experienced industry insiders touch and use our product, which is the best focus group you could hope for pre-launch,” said Dan Hoff, COO of VPR Brands. “The level of excitement and encouragement from these key industry professionals on the finished product and pricing was motivating and reaffirmed our eagerness to get these new lighters into the market as planned.”

To view the full press release, visit https://cnw.fm/sLIBT

About VPR Brands LP

VPR Brands develops consumer and business products based on the newest cutting-edge technologies and whose assets include an issued U.S. patent for atomization-related products, including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids, vaporizers and electronic cigarettes (also known as e-cigarettes), which are devices that deliver nicotine and or cannabis through atomization or vaping and without smoke and other chemical constituents typically found in traditional products. For more information about the company, visit www.VPRBrands.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Schumer Updates Advocates About Cannabis Banking and Federal Cannabis Legalization

Last week, Senate Majority Leader Chuck Schumer discussed social equity issues during a meeting with a number of cannabis advocacy and reform groups. Schumer is preparing to introduce the Cannabis Administration and Opportunity Act later this year.

In an interview, activists who were part of the Zoom meeting stated that the Senate Majority Leader wasn’t clear on when he would be filing his marijuana legalization measure, only noting that he would do it soon. The implementation of the adult-use cannabis program in New York, immigration issues associated with marijuana and cannabis banking were also discussed during the meeting.

Representatives of VOCAL-NY, Women Grow, Immigrant Defense Project, Cannabis Regulators of Color Coalition, the Drug Policy Alliance and the Rochester NORML chapter took part in the discussion.

Schumer also revealed during the meeting that he’d received criticism from advocates about how long it had taken to file his legalization measure. He noted that both he and his colleagues at the Senate felt that it was important to make sure that equity was effectively integrated into the measure before the committee processes begun.

Last year, the Senate Majority Leader observed that he wanted to keep major players in the tobacco and alcohol industries out of the cannabis industry, in favor of creating opportunities for smaller businesses when the plant was federally legalized. His soon-to-be filed legislation is designed to ensure that these big companies don’t overtake the industry.

The director of National Affairs for the Drug Policy Alliance stated in an interview that Schumer made it clear in the meeting that he understood that social equity needed to be a crucial and intentional part of any cannabis measure that was advanced in Congress. She also pointed out that her organization looked forward to working with Schumer’s office on a comprehensive cannabis initiative that would offer restitution to communities and individuals who were severely impacted by cannabis prohibition.

Cannabis Regulators of Color Coalition vice chair Shaleen Title stated that the Senator had consistently stood with minority-owned businesses as well as small businesses, adding that they were glad to share lessons for how Congress could help ensure that communities which had been affected by the war on drugs could thrive.

During the meeting, Schumer also recognized that until federal prohibition on marijuana was lifted, the system wouldn’t be thoroughly equitable in states such as New York where regulators were working to implement an adult-use cannabis market.

When federal cannabis legalization finally happens, the marijuana industry, including companies such as Flora Growth Corp. (NASDAQ: FLGC), will breathe a collective sigh of relief since some of the hurdles they face will have been removed.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — NFL Authorizes Grants Worth $1M for Studies on Marijuana and Pain Management

Last week, the NFL announced that it had issued grants worth $1 million for research studies. The studies would look into the effectiveness of using marijuana and its components in pain management and offering neuroprotection from concussions among NFL players. Out of 100 applicants, the commission selected the University of California San Diego and University of Regina, which is located in Canada.

This is the league’s attempt to provide its players with quality care that is up-to date with the medical standards of health and safety. Allen Sills, the league’s chief medical officer, said this opportunity would provide its players with scientifically backed information on how the use of cannabinoids would impact their performance.

Researcher Kevin Hill told the Associated Press that the reason why there is a limited body of research on marijuana’s potential use for pain management is because it is a federally controlled substance. Hill said that industry stakeholders do not want to back similar research because of the wide availability and consumption of cannabis products.

Funding for the research was first previewed in June 2021 after a growing interest among stakeholders and players who were looking for an alternative to opioids as well as exploring the benefits of using cannabis for therapeutic purposes.

Mark Wallace from UC San Diego Health was excited that his team would be working with the professional players to shed further light on how cannabis is useful in pain management.

This research initiative is expected to take three years with the key areas of focus being the effects of cannabinoids in pain management, the effects of nonpharmacologic treatments and the effects of cannabis on athletic performance.

Professor Patrick Neary from the University of Regina said that the core of his research will be on the prevention and treatment of concussions. He believes that formulations found in medical cannabis can be useful to athletes who have acute and long-term chronic effects of concussions.

In 2020 after a collective bargaining agreement, the league increased the threshold of what makes a positive THC test. Moreover, NFL players would get fined instead of facing suspensions after the drug tests came back positive. However, there is no guarantee that the findings from the research would help in revising the league’s policy on banning players who use the drugs.

Recently, other sport leagues have been revising their drug-testing policies. Last year, the NBA announced that it would not subject its players to THC tests. However, they would look out for cases where players have a history of substance use. The MLB removed marijuana from its list of banned substances in 2019. Despite this, baseball players are not allowed to work while under the influence or receive sponsorship contracts from cannabis businesses.

Meanwhile, the World Anti-Doping Agency will conduct a scientific review of marijuana this year in order to determine whether its athletes can remain internationally banned from using cannabis.

Such studies are likely to add to the existing body of knowledge regarding the potential health effects of the marijuana products made by various companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS).

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Reaches ‘Major Milestone,’ Closes on Acquisition

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, through its wholly owned subsidiary RWB Michigan LLC, has closed on the acquisition of PharmaCo Inc. The acquisition, which was originally announced in 2020, brings an extensive list of assets to RWBYF, including 21 medical and adult-use cannabis licenses, eight fully operating dispensaries with five dually licensed, two operational indoor cultivation facilities totaling more than 30,000 square feet, one municipally licensed 10-acre outdoor cultivation facility ready for the 2022 season, two ready-to-open dispensaries, and22 owned properties for potential additional cultivation and dispensary locations. With the acquisition, Red White & Bloom also becomes fully licensed and integrated from seed-to-sale for medical and adult-use cannabis in one of the top markets in the country; Michigan reported an estimated $1.79 billion in cannabis sales last year. “I’m pleased to announce that we have closed on the PharmaCo acquisition and now control all aspects of our Michigan operations,” said Red White & Bloom chair and CEO Brad Rogers in the press release. “This is a major milestone for RWB and its shareholders as we continue to execute key components of our growth strategy and build our house of brands across our core markets, as promised. We are now in the driver’s seat on over 20 assets across Michigan — one of the largest and fastest growing cannabis markets in the country. . . . As we take full control of our Michigan operations from seed- to-sale, our anticipated 2022 initiatives include extending our branded product lines, updating our dispensaries to heighten the customer experience, creating supply chain efficiencies and growing revenue and profitability.”

To view the full press release, visit https://cnw.fm/iorxi

About Red White & Bloom Brands Inc.

Red White & Bloom Brands is positioning itself to be one of the top-three multistate cannabis operators active in the U.S. legal cannabis and hemp sectors. RWB is predominantly focusing its investments on major U.S. markets, including Michigan, Illinois, Massachusetts, California and Arizona with respect to cannabis, as well as the United States and internationally for hemp-based CBD products. For more information about the company, please visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces New Chief Strategy Officer

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has named Vessel founder and CEO James Chose as its new chief strategy officer. Choe brings impressive experience to his new role, with exposure to almost every major industry and a consulting business that has worked with more than 100 brands to launch more than 400 products. In particular, his time spent consulting for leading brands, cannabis producers and Fortune 500 companies has prepared Choe to serve as chief strategy office, where he will work on developing three core pillars: people, design, and community. Choe is focused on making Flora the most thoughtful organization in the industry as the company builds a unique value proposition, protects its people-first organization, is relentless in its pursuit of designing better experiences and develops a culture of operational excellence. Choe came to Flora Growth via the company’s 2021 acquisition of Vessel, an industry leader in premium cannabis consumption technology and accessories. Vessel provides a foothold for Flora in the North American market. In addition, Flora Growth announced that on Feb. 11, 2022; at 1 p.m. EST, CEO Luis Merchan will lead a webinar. The webinar will look at opportunities and challenges that lie ahead for the CBD industry in North America, Latin America and the European Union. “We are excited not only to have added an incredible company like Vessel to our brand portfolio but to be welcoming such a skilled entrepreneur as James Choe to our executive team,” said Flora Growth CEO Luis Merchan in the press release. “James brings an unparalleled passion to the organization. He has always been a people-first leader and his ability to craft a company culture and strategy built in service of the team has already started to create tangible results. We look forward to him growing his contributions.”

To view the full event, visit https://cnw.fm/rOtjv

To view the full press release, visit https://cnw.fm/LJenV

About Flora Growth Corp.

Flora is building a design-led collective of plant-based wellness and lifestyle brands that delivers the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — How Combining CBD with Adaptogens Achieves Better Results

The popularity of cannabidiol can be attributed in part to its purported anxiety- and stress-relieving properties. Its consumption will not get the user high because it is a nonpsychoactive compound of marijuana. The benefits of CBD have been embraced by the wellness community, and the compound can be found in beverages, edibles, capsules and oils.

Aside from cannabidiol, adaptogens are also receiving a similar level of attention. These are plants that provide the body with stress-coping mechanisms as well as regulate hormonal changes. Other benefits include reducing inflammation, fighting fatigue and improving sleep. The use of adaptogens has been popular in Asian countries among those who follow the Ayurvedic medicine system.

There are a variety of adaptogens with the popular ones being rhodiola, reishi mushrooms, tulsi and ashwagandha. Rhodiola has been praised for its energy-boosting properties. Tulsi, or holy basil, boosts the body’s immunity as well as reduces anxiety, improves focus and helps manage depression. Ashwagandha is a stress reliever and has been a key ingredient in Ayurvedic potions. Reishi mushrooms provide the body with antioxidant properties that allow the skin to maintain a youthful look. Chaga, cordyceps and tocos are other popular adaptogens.

Adaptogens generally have a bitter taste, which is why they can be combined with cannabidiol. They are mostly manufactured as capsules or in powder form so that they can be added to beverages.

The body has a system of glands, receptors and hormones that form the hypothalamic pituitary adrenal (“HPA”) axis. Adaptogens seamlessly integrate with the system to restore metabolic equilibrium, also known as homeostasis. When our body is exposed to stressful situations, adaptogens will help in maintaining stress levels by lowering the production of stress hormones and refilling them when there’s an inadequacy.

Adaptogens are effective when they are taken for long durations because they will provide the body with internal stability. However, there are a couple of precautions you need to consider before you start ingesting adaptogens or taking them with CBD.

Talk to your doctor first. Ask for their recommendations and for clearance regarding which CBD and adaptogen products are suitable for you.
Take note of the United States Pharmacopeia (“USP”) seal when buying from the marketplace. Despite being nontoxic plants, they have not currently regulated by the FDA. The seal will let you know that which products have been verified by the USP.
Side effects can be experienced when adaptogens and/or CBD are paired with prescription drugs. Consult a naturopath or an herbalist to make sure they do not create undesirable effects with the ingredients of your prescribed medication.
Begin with smaller doses before increasing your intake. You can consult a naturopath or doctor to guide you with dosage. Some undesirable effects of taking sudden large doses of CBD include sleepiness while those for adaptogens include nausea, headaches and dizziness.

As this niche grows, many more companies are likely to jump into the fray. Flora Growth Corp. (NASDAQ: FLGC) is an internationally focused cannabis brand builder that is organically growing market share for its existing brand portfolio, which includes food & beverage.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Cannabis Degrees Becoming Popular as More Universities Offer Them

Huge numbers of students in the United States are considering studying marijuana-related programs in major universities, especially with the numerous job openings in the cannabis industry. Estimates show that the marijuana industry will support more than 400,000 jobs this year, based on the current rates of growth.

Recent reports also show that by 2029, cannabis jobs will have increased by at least 160%. This isn’t a surprise as the marijuana industry is a burgeoning industry, having grown by 47% since 2019. The industry is also the economic driver in some emerging markets globally, with total yearly sales for 2020 hitting $18 billion. Projections show that by 2030, this flourishing industry will be worth about $100 billion; it is currently valued at $60 billion.

Despite these promising figures and the need to fill various positions with appropriately trained and competent individuals, the lack of federal legislation for marijuana and related substances has called into question the legitimacy of these programs. The lack of federal accreditation agencies for these degrees doesn’t help either.

However, various labs across the country that received authorization from the Cannabis Testing Lab Accreditation Program can conduct research on various terpene and cannabinoid properties. Appropriate tests on residual solvents, heavy metals, microbial contaminants and pesticides can also be carried out by these laboratories.

Marijuana degrees aren’t limited to research alone. The cannabis space, which still has a lot of expansion to do, has equipped students for opportunities in chemistry, engineering, technology and math. Students interested in cannabis and all that it entails need to focus on medical marijuana innovations while also having knowledge on the lucrative opportunities for business in the space.

Many expect that when a cannabis federal legislation is approved, the necessary accreditation agencies will be created and financed. Currently, universities and colleges in the U.S. provide three to four years of marijuana education. Various cannabis companies are also providing their employees with scholarships to study at top institutions in the country. This includes companies such as like Steadfast Labs and Veriheal, which are offering yearly scholarships worth $1,200 to employees who are interested in pursuing a marijuana-related degree.

It should be noted that not all accredited universities provide full degrees in marijuana courses. Some offer a number of lessons, while others offer full-time and part-time classes.

Accredited schools investing time and funds in preparing students with cannabis education include the University of Denver, Lake Superior State University, Northern Michigan University and Thomas Jefferson University, which also offers postgraduate degrees in the same.

These academic institutions are in a way helping entities such as American Cannabis Partners fill the talent gap that makes finding the right employees a difficult task in the marijuana industry.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Top Financial Regulator Says Marijuana Sector Has Bright Future

In an interview with PBC conference, Rodney Hood, a financial regulator and board member National Credit Union Administration (“NCUA”), said that the marijuana sector has a bright future once it is fully legalized and infrastructure is set in place. During the interview, Hood suggested ways to deal with federal regulations that have seen banking institutions backing out on working with marijuana businesses.

Despite more states legalizing marijuana for recreational and medical use, the industry has not received backing from the financial services sector. This reluctance is due to the influence of federal prohibition on the sector.

Aside from that, rural markets provide an opportunity for cannabis businesses. With urban centers usually considered as the prime target market, rural communities get overlooked. That could change if Congress passes reform legislation that protects banks that work with cannabis businesses from facing penalties as a result of financial regulations.

The Secure and Fair Enforcement Banking Act, also referred to as SAFE Banking Act, is seen by many as a way to improve business efficiency in the cannabis industry with its intention of availing protected banking services. The bill is currently in the Senate after being cleared by the House five times in different forms. The bill is authored and sponsored by Democratic Congressman Ed Perlmutter who has said that he is irritated with its stalling despite both chambers of Congress having a Democratic majority. He said that when he retires from Congress at the end of this session, he will make sure that the bill has been passed.

Hood shares a similar stance, hoping that the bill gets passed soon. In the meantime, he says that credit unions and mainline banks should be ready to embrace the marijuana industry. With 38 states having legalized the use, the banking industry needs to be postured and prepared for what cannabis-related businesses are ready to offer.

A recent paper revealed that there was an increase in banking activities in states where marijuana is legal. A report released by the Financial Crimes Enforcement Network (FinCEN) last year revealed more banks are willing to work with cannabis businesses. The number of banking institutions serving marijuana clients went from 689 in the previous quarter to 706.

As for the SAFE Banking Act, a bipartisan coalition made up of two dozen governors is calling for Congress to enact it through the defense legislation, National Defense Authorization Act (“NDAA”).

When marijuana policy reforms are finally implemented at the federal level, the entire cannabis sector, including entities such as Cannabis Strategic Ventures Inc. (OTC: NUGS), will have fewer hoops to jump through in their daily operations.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.